Julia E. Weigand

Julia E. Weigand

Auto-generated profile, based on publicly available information

Julia E. Weigand

Institute of Pharmaceutical Chemistry University of Marburg 35032 Marburg Germany

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2007 in RNA
Verified
Journal Article
Closed access
JWJulia E. Weigand
Julia E. Weigand
MSMartin Sanchez
Martin Sanchez
EGEwald-Bernd Gunnesch
Ewald-Bernd Gunnesch
SZSabrina Zeiher
Sabrina Zeiher
RSRenee Schroeder
Renee Schroeder
BSBeatrix Suess
Beatrix Suess
Riboswitches are genetic control elements that regulate gene expression in a small molecule-dependent way. We developed a two-stage strategy of in vitro selection followed by a genetic screen and identified several artificial small molecule-binding riboswitches that respond to the aminoglycoside neomycin. Structure–function relationships and structural probing revealed that they adopt the general neomycin-binding motif. They display no sequence similarities to in vitro selected neomycin aptamers but contain parts of the decoding site that is the binding site for neomycin on the ribosomal RNA. We propose a model of a composed binding pocket of an internal loop as primary docking site and a terminal flaplike loop structure fixing neomycin in a sandwich-like manner. Such binding pockets characterized by multiple contacts between ligand and RNA are described for both natural and engineered riboswitches. We anticipate that combination of in vitro selection and in vivo screening is a useful strategy to identify RNA molecules with a desired functionality.

10 November 2020 in Nucleic Acids Research
Verified
Journal Article
Open access
AWAnna Wacker
Anna Wacker
JWJulia E Weigand
Julia E Weigand
SASabine R Akabayov
Sabine R Akabayov
NANadide Altincekic
Nadide Altincekic
JBJasleen Kaur Bains
Jasleen Kaur Bains
HZHeidi Zetzsche
Heidi Zetzsche
The current pandemic situation caused by the Betacoronavirus SARS-CoV-2 (SCoV2) highlights the need for coordinated research to combat COVID-19. A particularly important aspect is the development of medication. In addition to viral proteins, structured RNA elements represent a potent alternative as drug targets. The search for drugs that target RNA requires their high-resolution structural characterization. Using nuclear magnetic resonance (NMR) spectroscopy, a worldwide consortium of NMR researchers aims to characterize potential RNA drug targets of SCoV2. Here, we report the characterization of 15 conserved RNA elements located at the 5′ end, the ribosomal frameshift segment and the 3′-untranslated region (3′-UTR) of the SCoV2 genome, their large-scale production and NMR-based secondary structure determination. The NMR data are corroborated with secondary structure probing by DMS footprinting experiments. The close agreement of NMR secondary structure determination of isolated RNA elements with DMS footprinting and NMR performed on larger RNA regions shows that the secondary structure elements fold independently. The NMR data reported here provide the basis for NMR investigations of RNA function, RNA interactions with viral and host proteins and screening campaigns to identify potential RNA binders for pharmaceutical intervention.

1 January 2006 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
MMMichael Müller
Michael Müller
JWJulia E. Weigand
Julia E. Weigand
OWOliver Weichenrieder
Oliver Weichenrieder
BSBeatrix Suess
Beatrix Suess
Riboswitches reflect a novel concept in gene regulation that is particularly suited for technological adaptation. Therefore, we characterized thermodynamically the ligand binding properties of a synthetic, tetracycline (tc)-binding RNA aptamer, which regulates gene expression in a dose-dependent manner when inserted into the untranslated region of an mRNA. In vitro , one molecule of tc is bound by one molecule of partially pre-structured and conformationally homogeneous apo-RNA. The dissociation constant of 770 pM, as determined by fluorimetry, is the lowest reported so far for a small molecule-binding RNA aptamer. Additional calorimetric analysis of RNA point mutants and tc derivatives identifies functional groups crucial for the interaction and including their respective enthalpic and entropic contributions we can propose detailed structural and functional roles for certain groups. The conclusions are consistent with mutational analyses in vivo and support the hypothesis that tc-binding reinforces the structure of the RNA aptamer, preventing the scanning ribosome from melting it efficiently.

6 June 2007 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
JWJulia E. Weigand
Julia E. Weigand
BSBeatrix Suess
Beatrix Suess
Splicing of pre-mRNA is a critical step in mRNA maturation and disturbances cause several genetic disorders. We apply the synthetic tetracycline (tc)-binding riboswitch to establish a gene expression system for conditional tc-dependent control of pre-mRNA splicing in yeast. Efficient regulation is obtained when the aptamer is inserted close to the 5′splice site (SS) with the consensus sequence of the SS located within the aptamer stem. Structural probing indicates limited spontaneous cleavage within this stem in the absence of the ligand. Addition of tc leads to tightening of the stem and the whole aptamer structure which probably prevents recognition of the 5′SS. Combination of more then one aptamer-regulated intron increases the extent of regulation leading to highly efficient conditional gene expression systems. Our findings highlight the potential of direct RNA–ligand interaction for regulation of gene expression.

12 August 2010 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
EDElke Duchardt‐Ferner
Elke Duchardt‐Ferner
JWJulia E. Weigand
Julia E. Weigand
OOOliver Ohlenschlaeger
Oliver Ohlenschlaeger
SSSina R. Schmidtke
Sina R. Schmidtke
BSBeatrix Suess
Beatrix Suess
JWJens Wöhnert
Jens Wöhnert

3 August 2021 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
SSSridhar Sreeramulu
Sridhar Sreeramulu
CRChristian Richter
Christian Richter
HBHannes Berg
Hannes Berg
MMMaria A. Wirtz Martin
Maria A. Wirtz Martin
BCBetül Ceylan
Betül Ceylan
HSHarald Schwalbe
Harald Schwalbe
SARS‐CoV‐2 contains a positive single‐stranded RNA genome of approximately 30 000 nucleotides. Within this genome, 15 RNA elements were identified as conserved between SARS‐CoV and SARS‐CoV‐2. By nuclear magnetic resonance (NMR) spectroscopy, we previously determined that these elements fold independently, in line with data from in vivo and ex‐vivo structural probing experiments. These elements contain non‐base‐paired regions that potentially harbor ligand‐binding pockets. Here, we performed an NMR‐based screening of a poised fragment library of 768 compounds for binding to these RNAs, employing three different 1H‐based 1D NMR binding assays. The screening identified common as well as RNA‐element specific hits. The results allow selection of the most promising of the 15 RNA elements as putative drug targets. Based on the identified hits, we derive key functional units and groups in ligands for effective targeting of the RNA of SARS‐CoV‐2.